Home Newsfeeds Janney Montgomery Scott Downgrades Centerspace to Neutral

Janney Montgomery Scott Downgrades Centerspace to Neutral

Janney Montgomery Scott analyst Robert Stevenson downgrades Centerspace (NYSE:CSR) from Buy to Neutral.

byBenzinga Newsdesk

December 14, 2022

1 minute read

Janney Montgomery Scott analyst Robert Stevenson downgrades Centerspace (NYSE:CSR) from Buy to Neutral.

Sanofi Higher Dose Flu Vaccines Preferentially Recommended For Adults 65+ In CDC Morbidity And Mortality Weekly Report

By Benzinga Newsdesk

August 26, 8:04 AM

This recommendation may help reduce the risk of the flu and flu-related complications in this high-risk population Fluzone® High-Dose Quadrivalent (Influenza Vaccine) and

SNY

INmune Bio Data At ASH Highlight Innovative Natural Killer Cell Therapeutic Platform Showing 100+ Day Persistence Of Cancer Killing Memory Like NK Cells In Patients With AML/MDS Following Treatment With INKmune

By Benzinga Newsdesk

December 8, 9:10 AM

INmune Bio, Inc. (NASDAQ:INMB) ("INMB" or "the Company"), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system

INMB